The FDA has issued draft guidance outlining ways in which some prescription drugs could be made available to consumers without a prescription.
FDA Commissioner Scott Gottlieb, MD, said the agency’s “hope is that the steps we’re taking to advance this new, more modern framework will contribute to lower costs for our health care system overall and provide greater efficiency and empowerment for consumers by increasing the availability of certain products that would otherwise be available only by prescription.”
Voelker R. No Prescription Needed? JAMA. 2018;320(7):634. doi:10.1001/jama.2018.11596
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: